EP2165610B1 - Agent de lutte contre le tympanisme abdominal pour ruminants - Google Patents

Agent de lutte contre le tympanisme abdominal pour ruminants Download PDF

Info

Publication number
EP2165610B1
EP2165610B1 EP08777112A EP08777112A EP2165610B1 EP 2165610 B1 EP2165610 B1 EP 2165610B1 EP 08777112 A EP08777112 A EP 08777112A EP 08777112 A EP08777112 A EP 08777112A EP 2165610 B1 EP2165610 B1 EP 2165610B1
Authority
EP
European Patent Office
Prior art keywords
cashew nut
bloat
feed
nut shell
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP08777112A
Other languages
German (de)
English (en)
Other versions
EP2165610A1 (fr
EP2165610A4 (fr
Inventor
Yasuo Kobayashi
Kyo Nagashima
Masami Mochizuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hokkaido University NUC
Idemitsu Kosan Co Ltd
Original Assignee
Hokkaido University NUC
Idemitsu Kosan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokkaido University NUC, Idemitsu Kosan Co Ltd filed Critical Hokkaido University NUC
Publication of EP2165610A1 publication Critical patent/EP2165610A1/fr
Publication of EP2165610A4 publication Critical patent/EP2165610A4/fr
Application granted granted Critical
Publication of EP2165610B1 publication Critical patent/EP2165610B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Definitions

  • the present invention relates to an agent for use in controlling bloat in a ruminent, wherein the agent comprises cashew nut shell liquid. Furthermore, the present invention relates to an agent for use in controlling rumen acidosis in a ruminent, wherein the agent comprises cashew not shet liquid.
  • Staphylococcus aureus is a bacterium causing mastitis, subcutaneous tumor, and pyemia of bovines, sheep, and goats, anthema of horses, and arthritis, dermatitis, and ichorrhemia of pigs and chickens.
  • Streptococcus suis is a bacterium causing meningitis, ichorrhemia, endocarditis, and arthritis of pigs
  • Streptococcus bovis is a bacterium causing a bloat of bovines.
  • the bloat refers to the following state: rumen juice is formed into a foamed state so that gas is not separated from liquid, and the accumulated gas cannot be expelled by eructation.
  • the gas compresses the heart and the lungs, and the animal dies when it is left as it is.
  • Streptococcus bovis increases in the rumen, and the rumen juice is formed into a foamed state due to the generated viscous substance.
  • Non-patent Document 1 Non-patent Document 1
  • Patent Document 2 a coccidiosis-relieving action
  • the cashew nut shell liquid has antibacterial action against Gram-positive bacteria such as Staphylococcus aureus , Streptococcus mutans , Bacillus subtilis, and Bacillus ammoniagenes , and does not have antimicrobial action against Gram-negative bacteria such as Escherichia coli, Enterobacter aerogenes, and Pseudomonas aeruginosa , and against fungi such as Saccharomyces cerevisiae, Candida utilis , and Penichillium chrysogenum (Non-patent Document 2).
  • the antibacterial action of the cashew nut shell liquid against S. bovis is not known, and there is no report at all on the preventive effect against a bloat.
  • An object of the present invention is to suppress a bloat of a ruminant.
  • the inventors of the present invention have conducted intensive studies in order to solve the above problem, and as a result, the inventors have found that cashew nut shell liquid can be used for the control of a bloat and rumen acidosis in a ruminant. Thus, the inventors of the present invention have completed the present invention.
  • the present invention is as follows:
  • the bloat controlling agent of the present invention can be used for controlling a bloat of a ruminant.
  • a bloat controlling agent for a ruminant of the present invention includes cashew nut shell liquid (CNSL).
  • the cashew nut shell liquid to be used in the present invention is an oily liquid contained in the shell of the seed of a cashew nut tree ( Anacardium occidentale L. ) .
  • the cashew nut shell liquid contains, as the components thereof, anacardic acids, cardanol, and cardol.
  • the cashew nut shell liquid used in the present invention can be obtained as a vegetable oil extracted by compressing the shell of a cashew nut. Further, the cashew nut shell liquid used in the present invention can also be obtained by heating or extracting, e.g., dry-distilling or solvent-extracting a cashew nut shell. In addition, the cashew nut shell liquid used in the present invention can be obtained according to a method described in JP 08-231410 A .
  • the cashew nut shell liquid used in the present invention may also be a heat-sterilized oil and a liquid obtained by pulverizing/crushing the shell of a cashew nut.
  • a commercially-available product may also be used for the cashew nut shell liquid used in the present invention.
  • the content of the cashew nut shell liquid in the bloat controlling agent of the present invention is, from the view points of effects and costs, preferably 10 mass% to 100 mass%, more preferably 5 mass% to 90 mass%, and still more preferably 10 mass% to 80 mass%, with respect to a total amount of the controlling agent.
  • the content is 1 mass% or more, the bloat controlling effect can be exhibited with a predetermined amount of the controlling agent.
  • a stock solution of cashew nut shell liquid may be directly orally administered.
  • control includes both prevention and therapy.
  • the bloat controlling agent of the present invention can be used to control the bloat caused by Streptococcus bovis.
  • the bloat in the present invention includes a bloat caused by leguminous pasture or concentrated feed, and the bloat controlling agent of the present invention also has an effect on such a bloat.
  • the bloat controlling agent of the present invention may further contain, in addition to the cashew nut shell liquid, (an) arbitrary component(s) such as a component which is effective for the growth promotion of a ruminant, a nutritional supplement component, a component for enhancing the preservation stability.
  • (an) arbitrary component(s) such as a component which is effective for the growth promotion of a ruminant, a nutritional supplement component, a component for enhancing the preservation stability.
  • Examples of the arbitrary components include the followings: probiotics such as Enterococcus , Bacillus , and Bifidus ; enzymes such as amylase and lipase; vitamins such as L-ascorbic acid, choline chloride, inositol, and folate; minerals such as potassium chloride, iron citrate, magnesium oxide, and phosphates; amino acids such as DL-alanine, DL-methionine, L-lysine; organic acids such as fumaric acid, butyric acid, lactic acid, acetic acid, and their salts; antioxidants such as ethoxyquin, dibutylhydroxytoluene, butylhydroxy anisole, ferulic acid, vitamine C, and vitamine E; fungicides such as calcium propionate; binders such as carboxylmethyl cellulose (CMC), casein sodium, and sodium polyacrylate; emulsifiers such as lecithin, glycerin fatty acid ester and sorbit
  • the formulation of the bloat controlling agent of the present invention is not particularly limited, and the agent may be in an arbitrary form such as powder, liquid, solid, a tablet, a capsule, or emulsion.
  • the bloat controlling agent of the present invention can be produced by mixing cashew nut shell liquid and, if required, an arbitrary component, and forming the mixture into a preparation. Note that, depending on the form of the formulation, the pulverized/crushed product of the above-mentioned cashew nut shell or the cashew nut shell as it is without being subjected to any treatment is mixed with another arbitrary component, and the mixture can be used as the bloat controlling agent of the present invention.
  • the pulverized/crushed product as it is or the cashew nut shell as it is may be used as the bloat controlling agent, and the bloat controlling agent itself may be used as a composition for a feed or a feed.
  • the composition for a feed of the present invention includes cashew nut shell liquid. Further, the composition for a feed of the present invention may also include the bloat controlling agent.
  • the content of the cashew nut shell liquid in the composition for a feed of the present invention is, from the viewpoints of effects and costs, preferably 0.5 to 500,000 mass ppm, more preferably 5 to 100,000 mass ppm, and still more preferably 50 to 50,000 mass ppm with respect to a dry mass of the composition for a feed.
  • the bloat controlling agent of the present invention is mixed with another feed component used in pet foods and supplements for pets (hereinafter referred to as feed), to thereby produce a feed.
  • feed another feed component used in pet foods and supplements for pets
  • the feed of the present invention includes cashew nut shell liquid.
  • the feed may also include the above-mentioned composition for a feed.
  • the content of the cashew nut shell liquid in the feed of the present invention is, in terms of effect and cost, preferably 0.5 to 50,000 mass ppm, more preferably 5 to 10,000 mass ppm, and still more preferably 50 to 5,000 mass ppm with respect to a dry mass of the feed.
  • the feed of the present invention can be produced by adding cashew nut shell liquid or a composition for a feed including the cashew nut shell liquid as it is to a feed component and mixing the resultant.
  • a powdery or solid composition for a feed when used, the form of the composition for a feed may be modified into a liquid form or a gel form for the purpose of facilitating the mixing process.
  • the following may be used as a liquid carrier: water; a vegetable oil such as soybean oil, rapeseed oil, or corn oil; or a water-soluble polymer compound such as a liquid animal oil, polyvinylalcohol, polyvinylpyrrolidone, or polyacrylic acid.
  • the feed also preferably contains alginic acid, sodium alginate, xanthan gum, casein sodium, gum arabic, guar gum, or water-soluble polysaccharides such as tamarind seed polysaccharide.
  • the species of animals that ingest the feed of the present invention are ruminants.
  • the feedof the present invention is suitable for breeding ruminants such as cows, goats, and sheep.
  • the amount of feed ingested by an animal may be appropriately adjusted depending on the animal's species, body weight, age, sex, health condition, feed component, etc.
  • the amount of cashew nut shell liquid contained in the feed is preferably 0.005 to 500 g per ruminant per day, more preferably 0.5 to 100 g per ruminant per day, and still more preferably 0.5 to 50 g per ruminant per day. Any method usually used may be adopted as a method of feeding animals and a method of breeding animals depending on the species of animals.
  • CNSL also has high antibacterial action against S. bovis in the same manner as against Staphylococcus aureus and Bacillus subtilis , which are Gram-positive bacteria.
  • S. bovis is a bacterium which is present in the rumen and is considered as one of the bacteria causing a bloat. Therefore, it is thought that, as one of the working mechanisms of the bloat controlling agent of the present invention, the proliferation of S . bovis can be suppressed in the rumen by administering CNSL, thereby being capable of preventing a bloat.
  • Table 2 shows the pH of the rumen juice.
  • CNSL has an effect of preventing pH decline of the rumen juice. That is, it is found that CNSL has an effect of controlling rumen acidosis which causes rumen juice to be oxidized and deteriorates the rumen function.
  • Table 3 shows the viscosity of the rumen juice (CP), the foamability of the rumen juice (IVI (%)), and the foam stability of the rumen juice (sIVI (%)).
  • Bovine bloat is such a disease that rumen juice is formed into a foamed state and the bovine becomes unable to expel gas by eructation, so the gas is accumulated in the rumen and causes bloating in the abdomen.
  • the gas compresses the heart and the lungs, leading to death.
  • the viscosity, foamability, and foam stability of the rumen juice each lowered by the administration of CNSL, and each increased when the administration was stopped. That is, it is found that CNSL has an effect of controlling the bloat.
  • a bloat When a ruminant is raised by allowing them to ingest cashew nut shell liquid, a bloat can be controlled.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Claims (8)

  1. Agent pour une utilisation dans le contrôle du tympanisme (bloat) chez un ruminant, ledit agent comprenant un liquide de coque de noix de cajou.
  2. Agent pour une utilisation selon la revendication 1, dans lequel le tympanisme (bloat) est causé par Streptococcus bovis.
  3. Agent pour une utilisation selon la revendication 1 ou 2, dans lequel l'agent est sous la forme d'un aliment.
  4. Utilisation d'un liquide de coque de noix de cajou dans la fabrication d'un agent pour contrôler le tympanisme (bloat) chez un ruminant.
  5. Utilisation selon la revendication 4, dans laquelle le tympanisme (bloat) est causé par Streptococcus bovis.
  6. Utilisation selon la revendication 4 ou 5, dans laquelle l'agent est sous la forme d'un aliment.
  7. Agent pour une utilisation dans le contrôle de l'acidose du rumen chez un ruminant, ledit agent comprenant un liquide de coque de noix de cajou.
  8. Utilisation d'un liquide de coque de noix de cajou dans la fabrication d'un agent pour contrôler l'acidose du rumen chez un ruminant.
EP08777112A 2007-06-08 2008-06-06 Agent de lutte contre le tympanisme abdominal pour ruminants Active EP2165610B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007153285 2007-06-08
JP2008029494 2008-02-08
PCT/JP2008/060492 WO2008149994A1 (fr) 2007-06-08 2008-06-06 Agent de lutte contre le tympanisme abdominal pour ruminants

Publications (3)

Publication Number Publication Date
EP2165610A1 EP2165610A1 (fr) 2010-03-24
EP2165610A4 EP2165610A4 (fr) 2011-03-23
EP2165610B1 true EP2165610B1 (fr) 2013-03-27

Family

ID=40093797

Family Applications (2)

Application Number Title Priority Date Filing Date
EP08777110.1A Active EP2165609B1 (fr) 2007-06-08 2008-06-06 Agent améliorant la fermentation dans la panse
EP08777112A Active EP2165610B1 (fr) 2007-06-08 2008-06-06 Agent de lutte contre le tympanisme abdominal pour ruminants

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP08777110.1A Active EP2165609B1 (fr) 2007-06-08 2008-06-06 Agent améliorant la fermentation dans la panse

Country Status (14)

Country Link
US (2) US8349370B2 (fr)
EP (2) EP2165609B1 (fr)
JP (2) JP5424401B2 (fr)
KR (2) KR101486611B1 (fr)
CN (2) CN101677596A (fr)
AU (2) AU2008260898B2 (fr)
BR (2) BRPI0812886B1 (fr)
CA (2) CA2689604A1 (fr)
CO (2) CO6150098A2 (fr)
DK (1) DK2165610T3 (fr)
ES (2) ES2444442T3 (fr)
NZ (2) NZ581527A (fr)
RU (2) RU2009149163A (fr)
WO (2) WO2008149992A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2738819A1 (fr) * 2008-09-29 2010-04-01 Idemitsu Kosan Co., Ltd. Agent therapeutique pour les tympanites chez un ruminant
WO2010053085A1 (fr) * 2008-11-04 2010-05-14 出光興産株式会社 Agent de prévention de l'acidose chez des ruminants
MX2011006273A (es) * 2008-12-12 2011-06-27 Idemitsu Kosan Co Alimento para prevenir y/o tratar enfermedades debido a la bacteria clostridium sp. en ganado y agente anti-clostridium.
WO2010071222A1 (fr) * 2008-12-20 2010-06-24 味の素株式会社 Inhibiteur d'émission de méthane pour ruminants et composition alimentaire
KR20120051725A (ko) * 2009-07-30 2012-05-22 이데미쓰 고산 가부시키가이샤 코트 제제
NZ604839A (en) * 2010-06-03 2014-07-25 Idemitsu Kosan Co Cashew nut shell liquid having improved stability
FR2966603B1 (fr) * 2010-10-21 2012-11-16 Valorex Sa Procede d'evaluation de la quantite de methane produite par un ruminant laitier
KR20130099169A (ko) * 2010-11-05 2013-09-05 이데미쓰 고산 가부시키가이샤 안정성이 향상된 캐슈 너트셸 오일
BR112013016346B1 (pt) * 2011-01-07 2019-03-06 Idemitsu Kosan Co., Ltd. Método de aperfeiçoamento de ao menos um dentre rendimento de leite e qualidade de leite de um ruminante, e, uso de ao menos um dentre líquido de casca de castanha de caju, líquido de casca de castanha de caju tratado por calor, ácido anacardico, cardanol e cardol
AU2016204291B2 (en) * 2011-01-07 2016-12-22 Sds Biotech K.K. Agent for improving milk yield and/or milk quality of ruminants, preventive or therapeutic agent for perinatal disease, and agent for improving reproductive efficiency
US20130224320A1 (en) * 2012-02-23 2013-08-29 Joan Torrent Campmany Process to improve feed efficiency and carcass characteristics of animals
EP3105581B1 (fr) * 2014-02-14 2021-10-13 GEA Farm Technologies GmbH Procédé et appareil de surveillance de la fermentation dans la panse d'un ruminant
US10588331B2 (en) 2014-11-26 2020-03-17 River Road Research, Inc. Method for converting food waste and other biological waste into invertebrate feed
CN106387353A (zh) * 2016-08-31 2017-02-15 广州市义和化工有限公司 一种饲料用组合物及其制造方法
AR120346A1 (es) 2019-10-31 2022-02-09 Idemitsu Kosan Co Agente para suprimir la resistencia a la insulina en rumiantes
JP7519661B2 (ja) 2019-12-03 2024-07-22 株式会社エス・ディー・エス バイオテック 腸管細胞の炎症抑制剤
US20240252572A1 (en) 2021-05-28 2024-08-01 Sds Biotech K.K. Anti-inflammatory agent for intestinal cells of domestic animal
WO2024075706A1 (fr) * 2022-10-03 2024-04-11 株式会社エス・ディー・エス バイオテック Inhibiteur de la production de méthane par un ruminant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2317611A (en) * 1939-12-07 1943-04-27 Harvel Corp Cashew nut shell liquid material compositions and bases carrying the same
JPH0781137B2 (ja) 1990-01-24 1995-08-30 御木本製薬株式会社 酸化防止剤
JP3217484B2 (ja) 1992-08-17 2001-10-09 株式会社リコー 高耐圧半導体装置
JPH08231410A (ja) * 1995-02-23 1996-09-10 Takasago Internatl Corp コクシジウム症軽減剤及びそれを含有する飼料
JP4680339B2 (ja) * 1999-11-26 2011-05-11 日清丸紅飼料株式会社 コクシジウム症の予防および／または治療用飼料
JP4783512B2 (ja) * 2001-03-27 2011-09-28 社団法人農林水産先端技術産業振興センター 反芻動物のメタン生成を抑制する飼料組成物
SE0400996D0 (sv) * 2004-04-16 2004-04-16 Alltech Ireland Inc Use of plants, plant extracts and nature-identical components from plants to affect the rumen fermentation and to improve the energy and protein retention of ruminants
JP2006166853A (ja) * 2004-12-17 2006-06-29 Ajinomoto Co Inc 反芻動物用のメタン生成抑制剤および飼料組成物

Also Published As

Publication number Publication date
DK2165610T3 (da) 2013-06-10
CA2689641A1 (fr) 2008-12-11
RU2009149163A (ru) 2011-07-20
NZ581527A (en) 2012-02-24
ES2444442T3 (es) 2014-02-25
WO2008149992A1 (fr) 2008-12-11
WO2008149994A1 (fr) 2008-12-11
BRPI0812884A2 (pt) 2014-10-07
EP2165609B1 (fr) 2013-12-04
CO6150098A2 (es) 2010-04-20
CA2689641C (fr) 2015-09-22
KR101486611B1 (ko) 2015-01-26
BRPI0812886B1 (pt) 2018-01-30
KR20100031611A (ko) 2010-03-23
US8349370B2 (en) 2013-01-08
EP2165610A1 (fr) 2010-03-24
CN101677596A (zh) 2010-03-24
US20100183755A1 (en) 2010-07-22
KR101477840B1 (ko) 2014-12-30
ES2406423T3 (es) 2013-06-06
CN101677597A (zh) 2010-03-24
CO6150099A2 (es) 2010-04-20
AU2008260898B2 (en) 2013-07-11
JPWO2008149994A1 (ja) 2010-08-26
US20100183756A1 (en) 2010-07-22
RU2009149164A (ru) 2011-07-20
EP2165609A1 (fr) 2010-03-24
AU2008260900A1 (en) 2008-12-11
BRPI0812886A2 (pt) 2014-10-07
EP2165609A4 (fr) 2011-03-16
JPWO2008149992A1 (ja) 2010-08-26
JP5424401B2 (ja) 2014-02-26
EP2165610A4 (fr) 2011-03-23
AU2008260900B2 (en) 2013-01-24
CA2689604A1 (fr) 2008-12-11
AU2008260898A1 (en) 2008-12-11
KR20100032411A (ko) 2010-03-25
NZ581528A (en) 2012-01-12

Similar Documents

Publication Publication Date Title
EP2165610B1 (fr) Agent de lutte contre le tympanisme abdominal pour ruminants
KR101652552B1 (ko) 가축의 클로스트리듐속 세균에 의한 질병의 예방 및/또는 치료용 사료, 그리고 항클로스트리듐제
US8012516B2 (en) Feeds containing hop acids and uses thereof as supplements in animal feeds
US20120077884A1 (en) Coccidiosis controlling agent and feed containing the same
EP2298082B1 (fr) Composition pour aliment et aliment en contenant
US20190150481A1 (en) Compositions and methods of improving dietary phosphorus and calcium utilization in animals
CA2738819A1 (fr) Agent therapeutique pour les tympanites chez un ruminant
JPWO2009139468A1 (ja) コクシジウム症防除剤およびそれを含有する飼料

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100105

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: IDEMITSU KOSAN CO., LTD.

Owner name: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSIT

A4 Supplementary search report drawn up and despatched

Effective date: 20110218

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/22 20060101ALI20110214BHEP

Ipc: A23K 1/16 20060101AFI20081223BHEP

Ipc: A23K 1/18 20060101ALI20110214BHEP

Ipc: A61K 36/18 20060101ALI20110214BHEP

Ipc: A61P 1/14 20060101ALI20110214BHEP

Ipc: A61P 3/00 20060101ALI20110214BHEP

17Q First examination report despatched

Effective date: 20111228

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 602792

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130415

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602008023273

Country of ref document: DE

Effective date: 20130523

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2406423

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20130606

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130627

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130627

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 602792

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130327

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130628

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130729

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130727

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20140103

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602008023273

Country of ref document: DE

Effective date: 20140103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130606

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130630

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20080606

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130606

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230522

REG Reference to a national code

Ref country code: NL

Ref legal event code: PD

Owner name: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY; JP

Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT; FORMER OWNER NAME: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY

Effective date: 20230815

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602008023273

Country of ref document: DE

Owner name: SDS BIOTECH K.K., JP

Free format text: FORMER OWNERS: IDEMITSU KOSAN CO., LTD., TOKYO, JP; NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, SAPPORO-SHI, HOKKAIDO, JP

Ref country code: DE

Ref legal event code: R081

Ref document number: 602008023273

Country of ref document: DE

Owner name: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVE, JP

Free format text: FORMER OWNERS: IDEMITSU KOSAN CO., LTD., TOKYO, JP; NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, SAPPORO-SHI, HOKKAIDO, JP

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20230706

Year of fee payment: 16

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20231019 AND 20231025

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

Owner name: SDS BIOTECH K.K.

Effective date: 20240611

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20240515

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240502

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240502

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20240612

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20240513

Year of fee payment: 17

Ref country code: FR

Payment date: 20240509

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20240522

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240702

Year of fee payment: 17